VIM
TMO icon

Vinva Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Vinva Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Sell
38,310
-3,205
-8% -$1.54M 0.13% 158
2026
Q1 		$19.9M Sell
41,515
-268
-0.6% -$145K 0.25% 100
2025
Q4 		$24.4M Buy
41,783
+9,527
+30% +$5.39M 0.3% 79
2025
Q3 		$14.9M Buy
32,256
+5,803
+22% +$2.7M 0.29% 83
2025
Q2 		$10.8M Buy
26,453
+6,150
+30% +$2.57M 0.28% 91
2025
Q1 		$10.2M Buy
20,303
+479
+2% +$259K 0.4% 57
2024
Q4 		$10.3M Buy
19,824
+1,502
+8% +$826K 0.39% 56
2024
Q3 		$11.3M Buy
18,322
+1,157
+7% +$685K 0.48% 44
2024
Q2 		$9.45M Buy
17,165
+2,460
+17% +$1.41M 0.47% 41
2024
Q1 		$8.55M Buy
14,705
+1,384
+10% +$777K 0.48% 43
2023
Q4 		$7.1M Buy
13,321
+1,905
+17% +$922K 0.48% 43
2023
Q3 		$5.74M Sell
11,416
-252
-2% -$134K 0.54% 39
2023
Q2 		$6M Sell
11,668
-1,762
-13% -$951K 0.52% 44
2023
Q1 		$7.56M Buy
+13,430
New +$7.57M 0.63% 34

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vinva Investment Management's TMO Position: Q2 2026 in Review

Vinva Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 7.7% in Q2 2026, selling an estimated $1.54M and leaving 38,310 shares worth $19.4M. The position accounts for 0.13% of the portfolio, ranked #158.

Vinva Investment Management first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $24.4M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Vinva Investment Management held 38,310 shares of Thermo Fisher Scientific worth $19.4M as of Q2 2026.
  • Vinva Investment Management sold 3,205 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.54M.
  • Thermo Fisher Scientific made up 0.13% of Vinva Investment Management's portfolio in Q2 2026, its #158 holding.
  • Vinva Investment Management first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Vinva Investment Management's Thermo Fisher Scientific position peaked at $24.4M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.